Sudha Warrier
Sudha Warrier
Manipal School of Regenerative Medicine
Verified email at
Cited by
Cited by
Potential role of natural compounds as anti-angiogenic agents in cancer
MK Shanmugam, S Warrier, AP Kumar, G Sethi, F Arfuso
Current vascular pharmacology 15 (6), 503-519, 2017
Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review
G Sethi, MK Shanmugam, S Warrier, M Merarchi, F Arfuso, AP Kumar, ...
Nutrients 10 (5), 645, 2018
Secreted frizzled related proteins: Implications in cancers
R Surana, S Sikka, W Cai, EM Shin, SR Warrier, HJG Tan, F Arfuso, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 53-65, 2014
Occurrence of vertebrate steroids, estradiol 17β and progesterone in the reproducing females of the mud crab Scylla serrata
SR Warrier, R Tirumalai, T Subramoniam
Comparative Biochemistry and Physiology Part A: Molecular & Integrative …, 2001
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial …
S Warrier, G Bhuvanalakshmi, F Arfuso, G Rajan, M Millward, ...
Cancer gene therapy 21 (9), 381-388, 2014
Role of novel histone modifications in cancer
MK Shanmugam, F Arfuso, S Arumugam, A Chinnathambi, B Jinsong, ...
Oncotarget 9 (13), 11414, 2018
Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt β-catenin signaling via the Wnt antagonist secreted frizzled …
G Bhuvanalakshmi, Basappa, KS Rangappa, A Dharmarajan, G Sethi, ...
Frontiers in pharmacology 8, 124, 2017
Receptor mediated yolk protein uptake in the crab Scylla serrata: crustacean vitellogenin receptor recognizes related mammalian serum lipoproteins
S Warrier, T Subramoniam
Molecular reproduction and development 61 (4), 536-548, 2002
The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
Z Ma, YY Wang, HW Xin, L Wang, F Arfuso, A Dharmarajan, AP Kumar, ...
The international journal of biochemistry & cell biology 108, 17-20, 2019
Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells
M Visweswaran, F Arfuso, S Warrier, A Dharmarajan
Stem cells 38 (1), 6-14, 2020
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties
F Arfuso, M Millward, A Dharmarajan, S Warrier
PloS one 10 (6), e0127517, 2015
The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignancies
IS Hiremath, A Goel, S Warrier, AP Kumar, G Sethi, M Garg
Journal of Cellular Physiology 237 (1), 199-238, 2022
Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
S Warrier, SK Balu, AP Kumar, M Millward, A Dharmarajan
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 21 …, 2014
‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling
MS Ong, W Cai, Y Yuan, HC Leong, TZ Tan, A Mohammad, ML You, ...
British Journal of Pharmacology 174 (24), 4684-4700, 2017
Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma
G Bhuvanalakshmi, N Gamit, M Patil, F Arfuso, G Sethi, A Dharmarajan, ...
Cancers 11 (1), 25, 2018
Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue
S Warrier, N Haridas, R Bhonde
Placenta 33 (10), 850-858, 2012
Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme
L Schiefer, M Visweswaran, V Perumal, F Arfuso, D Groth, P Newsholme, ...
Cancer gene therapy 21 (7), 297-303, 2014
Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays
S Warrier, P Pavanram, D Raina, M Arvind
Cell biology international 36 (12), 1137-1143, 2012
Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs
S Mandal, F Arfuso, G Sethi, A Dharmarajan, S Warrier
The international journal of biochemistry & cell biology 110, 59-69, 2019
Epigenetic reprogramming converts human Wharton’s jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
G Bhuvanalakshmi, F Arfuso, AP Kumar, A Dharmarajan, S Warrier
Stem cell research & therapy 8 (1), 1-15, 2017
The system can't perform the operation now. Try again later.
Articles 1–20